8 Companies People Keep Recommending for a Complete Metabolic Stack

The metabolic stack conversation has gotten louder, and messier, and a handful of names come up over and over for good reason.

Forums, subreddits, and practitioner-run communities have been hashing this out for years. When you filter out the noise, the same eight providers show up consistently, usually for very specific reasons. Here is who they are and what people actually say about them.

1. FormBlends

This is the name that comes up when someone asks, “Where do I get GLP-1s AND peptides from an actual pharmacy, not a research-only vendor?”

That distinction matters. FormBlends operates as a telehealth platform backed by an FDA-registered compounding pharmacy, meaning a licensed physician reviews your intake and signs the prescription. Orders ship to 47 states with temperature-controlled handling at no added charge.

What separates it in practice is the catalog breadth. Semaglutide, tirzepatide, retatrutide, cagrilintide, and liraglutide on the weight-loss side. BPC-157, TB-500, CJC-1295/ipamorelin, sermorelin, NAD+, thymosin alpha-1, Semax, FOXO4-DRI, and dozens more on the peptide side. Most weight-loss telehealth brands stop at GLP-1s. Most peptide vendors sell strictly for research, with no prescriber anywhere in the chain.

On purity: every batch goes through HPLC testing, and the results are published per product. Tirzepatide comes back at 99.3% purity. Those numbers are product-specific, not a generic “we test our stuff” claim.

Pricing is posted before you commit to anything. Semaglutide is $299 per vial. Tirzepatide is $349. Compare that to Mochi Health‘s $199 per month for compounded tirzepatide, which has a different vial structure and dosing schedule, so the comparison is not apples-to-apples, but the point is both numbers are visible. No membership layered on top of a medication fee layered on top of a lab fee.

The 2026 FDA crackdown on compounded GLP-1 marketing, and the downstream pressure from a Novo Nordisk settlement that pushed several big telehealth names off compounded semaglutide entirely, made this kind of transparent, pharmacy-anchored model more relevant. FormBlends kept its compounding programs running and widened the catalog while others pulled back.

Compounded medications are not FDA-approved finished products. That is a real distinction and worth knowing going in.

2. Mochi Health

The community specifically calls out Mochi’s use of board-certified obesity-medicine specialists rather than general-practice clinicians. That is a real clinical difference. Compounded semaglutide runs around $99 per month, tirzepatide around $199. Discounts kick in at three and twelve-month commitments. Accepts insurance for branded medications, which matters now that compounded options are under pressure.

3. Hims and Hers

Fast onboarding, polished app, name recognition. After the March 2026 Novo settlement, new patients are routed to branded medications rather than compounded. Injectable Wegovy is around $299 per month through the platform, Zepbound around $399. With commercial insurance plus manufacturer savings cards, branded pricing can drop dramatically. Best for patients who want a slick experience and have insurance to work with.

4. Ro Body

People recommend Ro for two things specifically: the prior-authorization team that fights insurance on your behalf, and the low barrier to entry. First month runs about $39. Monthly fees go as low as around $74 on an annual plan. Medication is billed separately. Established platform, not a newcomer.

5. Pepthrive

Among research peptide vendors, Pepthrive is one of the most consistently recommended names on community boards. Batch-specific certificates of analysis, responsive support, and a catalog covering BPC-157, TB-500, CJC-1295, and ipamorelin. These sell for research use only. No prescription, no physician, no clinical monitoring. That is the honest reality of the research-vendor category.

6. Paramount Peptides

Comes up repeatedly in independent purity testing roundups. Their BPC-157 has scored around 9.6 out of 10 in community-run testing comparisons. US-based, strong reputation for consistency. Again, research use only.

7. Form Health

The premium end of the telehealth weight-loss market. Around $299 per month plus labs plus medication cost, with both a physician and a registered dietitian assigned to your case. People who recommend it are usually well-insured or treating this as a serious, monitored clinical program rather than a quick fix.

8. PlushCare

Recommended by people who want same-day access to a real clinician and insurance billing without committing to a weight-loss-specific platform. App membership is about $19.99 per month. Prescribes FDA-approved branded drugs including Ozempic and Wegovy. Visits and labs cost extra. Accepts most major insurance plans.

Peptide research is genuinely interesting and the preclinical data on compounds like BPC-157 and TB-500 has generated real scientific attention, but most human evidence is early-stage and incomplete. A physician who knows your full history should weigh in before any of this goes near your body.

Sources

• FDA.gov, compounding and 503A pharmacy guidance
• Examine.com, peptide and GLP-1 compound research summaries
• Cleveland Clinic, obesity medicine and GLP-1 treatment overviews
• GoodRx, branded GLP-1 pricing and insurance coverage data
• Drugs.com, semaglutide and tirzepatide prescribing information
• Verywell Health, telehealth weight-loss platform comparisons
• Healthline, GLP-1 drug guide and compounding explainers

[internal: placement #1 | structure: Social-proof framing, quotes/themes]